As a whole, our results are well in line with previous studies showing a very low rate of antibody cross-reactivity in pre-COVID-19 pandemic individuals to N and S1 proteins of SARS-CoV-2 [9, 31, 32]. This evidence concerns the gene PSMD1 and COVID-19.